Lentinus edodes has good anti-tumor and anti-virus effects, and has long been the first-line clinical drug for anti-tumor and anti-hepatitis virus in China. There are many kinds of mushroom products, and many patients and their families don't know how to choose brands, so they often fall into misunderstanding:
Myth 1: Mushrooms are everywhere. Eating more mushrooms has the same effect.
Expert: Although lentinan is extracted from shiitake mushrooms, the content of lentinan in each shiitake mushroom is limited. Normal people eat more mushrooms, which is good for their health. For patients with liver disease or tumor, the effective components of lentinan ingested by eating mushrooms are very small and have no effect at all.
The extraction of lentinan is a high-tech process, which requires modern equipment and technology. For example, the lentinan capsule produced by Hubei Li Chuang Pharmaceutical Co., Ltd. adopts the top patent technology at home and abroad-separation and purification technology (national invention patent number ZL00 1 14433.2, international patent main classification number C08B 37/00). In June 2009, the project was reported to the provincial development and reform commission and approved.
Therefore, it is unscientific to eat more mushrooms to treat tumors or liver diseases.
Myth 2: covet cheap, health care products or brand-name products should be used as medicine.
Expert: There are many lentinan products, and there are four main categories in the market:
1 class: injection-the approval number is "National Medicine Zhunzi H", which belongs to chemical medicine and has been widely used in major hospitals, and it is in the medical insurance catalogue of most hospitals.
The second category: capsules-the approval number is "National Medicine Zhunzi Z", which belongs to Chinese patent medicine and has no side effects. It has been widely used in major hospitals and listed in the medical insurance catalogue of a few hospitals.
Category III: Tablets-The approval number is "Shi Guojian Zi" or "Shi Zhun Zi", which belongs to health care products or ordinary foods and has no therapeutic effect. There are many online or health care products sold, but hospitals can't sell them.
1 and 2/are batch numbers of "National Medicine Zhunzi", and the price is relatively expensive, about 2,500 a month. The third category is health care products or ordinary foods, and the price is naturally much cheaper. Many patients are ignorant and greedy for cheap, and as a result, they buy health care products that can't cure diseases as medicine, which delays their illness.
Many patients reported: "I bought the lentinan tablets of' National Medicine Zhunzi'. How is the effect not good? " Here we want to remind you, we must see clearly that this is not "lentinan", but "lentinan". There is a certain difference. The price of the latter is less than that of the former 1/3. I can only say that you are greedy for petty gain and cheap gain.
Myth 3: Mushrooms with medical insurance are the best, but those without medical insurance are not good.
Expert: Whether a drug enters medical insurance is not necessarily related to the effect of the drug itself. In other words, a drug that can enter medical insurance will definitely have a stable effect, but it is not necessarily the best. Drugs that enter medical insurance may be the most stable and best when they enter the medical insurance catalogue, but with the continuous emergence of new drugs, the effect ranking may fall behind. Many patients often ask this question: This new drug you mentioned has the best effect, but why can't it get into medical insurance?
According to China's medical insurance policy, new drugs should not only have good effects, but also check whether new drugs can replace or supplement the old drugs in the catalogue. For example, Lentinus edodes injection has been listed in the medical insurance catalogue, and Lentinus edodes capsule, as an out-of-hospital oral drug, can produce good "complementarity" to Lentinus edodes injection, so that patients can realize "seamless treatment inside and outside the hospital", so many hospitals in Beijing, Hunan, Guangdong, Liaoning and other provinces have entered the medical insurance catalogue.
Because the purchasing time of hospitals in different provinces in China, even hospitals in the same province, is inconsistent, with the passage of time, lentinan capsules in major hospitals in China can achieve full coverage of medical insurance within 2-3 years, and before that, they can only be purchased at hospitals' own expense pharmacies.
From the case of lentinan capsules, we can see that the same drug has been covered by medical insurance in this province, but not necessarily in other provinces. Even in the same province, this hospital has been invited to bid for medical insurance, but another hospital has not yet bid. Therefore, medical insurance access cannot be the standard of drug effect.